4//SEC Filing
Moore David Scott 4
Accession 0001610717-25-000360
CIK 0001626971other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:34 PM ET
Size
5.3 KB
Accession
0001610717-25-000360
Insider Transaction Report
Form 4
Moore David Scott
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-02+30,000→ 30,000 totalExercise: $7.04Exp: 2035-10-02→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from October 2, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0002088466
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:34 PM ET
- Size
- 5.3 KB